U.S. Markets closed

Cancer Genetics, Inc. (CGIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.8100-0.1200 (-3.05%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.9300
Open3.9091
Bid3.8000 x 800
Ask3.8300 x 1200
Day's Range3.7650 - 3.9600
52 Week Range1.9200 - 10.3900
Volume29,513
Avg. Volume1,830,475
Market Cap9.552M
Beta (5Y Monthly)2.55
PE Ratio (TTM)N/A
EPS (TTM)-0.5680
Earnings DateAug 14, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – MVC, CGIX, MOBL, STND
    ACCESSWIRE

    SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – MVC, CGIX, MOBL, STND

    NEW YORK, NY / ACCESSWIRE / October 20, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:MVC Capital, Inc.

  • GlobeNewswire

    SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers

    WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of fiduciary duties and other violations of law related to Eidos’ agreement to be acquired by BridgeBio Pharma, Inc. Under the terms of the agreement, Eidos’ shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-eidos-therapeutics-inc.American Renal Associates Holdings, Inc. (NYSE: ARA) regarding possible breaches of fiduciary duties and other violations of law related to American Renal Associates’ agreement to be acquired by affiliates of Nautic Partners, LLC. Under the terms of the agreement American Renal Associates’ shareholders will receive $11.50 per share in cash. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-american-renal-associates-holdings-inc.MVC Capital, Inc. (NYSE: MVC) regarding possible breaches of fiduciary duties and other violations of law related to MVC Capital’s agreement to be acquired by Barings BDC, Inc. Under the terms of the agreement MVC Capital’s shareholders will receive $0.39492 in cash and 0.94024 of a share of Barings BDC per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-mvc-capital-inc.Cancer Genetics, Inc. (NASDAQ CM: CGIX) regarding possible breaches of fiduciary duties and other violations of law related to Cancer Genetics’ agreement to merge with StemoniX, Inc. Under the terms of the agreement, Cancer Genetics will issue a number of shares of Cancer Genetics common stock to StemoniX shareholders. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-cancer-genetics-inc.You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com.Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.Attorney advertising. Prior results do not guarantee a similar outcome.CONTACT:Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (Toll Free) (302) 295-5310 Fax: (302) 654-7530 info@rl-legal.com https://rl-legal.com

  • SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – CBMG, CGIX, VRTU, MOBL
    ACCESSWIRE

    SHAREHOLDER ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm – CBMG, CGIX, VRTU, MOBL

    NEW YORK, NY / ACCESSWIRE / October 14, 2020 / New York, New York-Halper Sadeh LLP, a global investor rights law firm, is investigating:Cellular Biomedicine Group, Inc.